Retatrutide 30 mg

RT-2026-023Lot 01260929230XAnalyzed October 23, 2026

Timeline

Ordered

October 19, 2026

Received

October 21, 2026

Analyzed

October 23, 2026

Sample

Name

Retatrutide 30 mg

Expected

Retatrutide

Amount

1 vial, lyophilized powder

Testing

Client

Evermore Evolutions

Test type

Content & purity

Method

HPLC-UV

Content, how much is in it

28.99mg

Label claim: 30 mg

Purity, how clean it is

>99%

by HPLC-UV peak area

Chromatogram

HPLC-UV

18.48 min, Retatrutide, >99%

Analyst Comments

White lyophilized powder, dark blue-cap vial, received sealed.

Analyst Signature

Max Barrett

Lab Director, PuriLab Analytical

Analysis date: October 23, 2026

Verification Code

RT-P0T9-IAI4

Verify at purilab.org/verify/RT-P0T9-IAI4

Scan to Verify

RT-P0T9-IAI4

Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.

PuriLab Analytical|admin@purilab.org

Page 1 of 1